(HealthDay)—A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ultrasonography (US), according to research ...
Leesburg, VA, July 15, 2021--According to ARRS' American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) ...
Response-Guided Neoadjuvant Chemo Beneficial in Breast CA A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results